Prague-based PPF Group has acquired a 19.2% stake in Autolus Therapeutics plc, a developer of T cell cancer...
Up To Date
Latest News
German and US researchers have found a biomarker that identifies tumours responding to CTLA-4 checkpoint...
French biotech Inotrem SA raised €39m to finance Phase IIb efficacy testing of its TREM1 blocker nangibotide...
Paris-based Ermium Therapeutics has completed a Series A financing to develop breakthrough auto-immune...
Leiden-based Pharvaris BV received a cash injection that will be used to push PHA121, the very first orally...
London and Boston-based 4BIO Ventures has raised US$50m to target early-stage developers of advanced therapies...
Share
